ArticleMolecules (Basel, Switzerland)2019
Profile of Bioactive Compounds in the Morphological Parts of Wild
Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Classification and Anti-Pathogens (Basel, Switzerland) · 2026Review
- Chromatographic Analysis and Enzyme Inhibition Potential ofPharmaceuticals (Basel, Switzerland) · 2025Article
- Article
- Analysis of Phenolic Compounds ofPlants (Basel, Switzerland) · 2024Article
- Endophytic Bacteria and Fungi Associated withPlants (Basel, Switzerland) · 2024Article
- Preliminary Identification and Quantification of Individual Polyphenols inPlants (Basel, Switzerland) · 2024Article
- Unraveling the Physicochemical, Nutritional and Antioxidant Properties of the Honey Produced from theFoods (Basel, Switzerland) · 2024Article
- Microwave Control ofPlants (Basel, Switzerland) · 2024Article
- Crosstalk between Myopia and Inflammation: A Mini Review.International journal of medical sciences · 2024Review
- Advances for pharmacological activities ofPharmaceutical biology · 2023Review
- Screening and Evaluation of Dermo-Cosmetic Activities of the Invasive Plant SpeciesPlants (Basel, Switzerland) · 2022Article
- Controlled growth of ZnO nanoparticles using ethanolic root extract of Japanese knotweed: photocatalytic and antimicrobial properties.RSC advances · 2022Article
- Fallopia Japonica and Prunella vulgaris inhibit myopia progression by suppressing AKT and NFκB mediated inflammatory reactions.BMC complementary medicine and therapies · 2022Article
- Japanese Knotweed Rhizome Bark Extract Inhibits Live SARS-CoV-2 In Vitro.Bioengineering (Basel, Switzerland) · 2022Article
- Antioxidant and Antimicrobial Biofoil Based on Chitosan and Japanese Knotweed (Antioxidants (Basel, Switzerland) · 2022Article
- New Approaches on Japanese Knotweed (Plants (Basel, Switzerland) · 2021Review
- Flavan-3-ols and Proanthocyanidins in Japanese, Bohemian and Giant Knotweed.Plants (Basel, Switzerland) · 2021Article
- (-)-Epicatechin-An Important Contributor to the Antioxidant Activity of Japanese Knotweed Rhizome Bark Extract as Determined by Antioxidant Activity-Guided Fractionation.Antioxidants (Basel, Switzerland) · 2021Article
- Profile and Content of Phenolic Compounds in Leaves, Flowers, Roots, and Stalks ofPharmaceuticals (Basel, Switzerland) · 2020Article
- Comparison of Three Domestications and Wild-Harvested Plants for Nutraceutical Properties and Sensory Profiles in Five Wild Edible Herbs: Is Domestication Possible?Foods (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The aim of this study was to determine the content of triterpenoids and polyphenols, and antioxidative activity in leaves, stalks, and roots of plants from the species
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.